
### [NCIT:C7706](http://purl.obolibrary.org/obo/NCIT_C7706)
**Label:** Childhood Non-Hodgkin Lymphoma

**Subclasses:** [NCIT:C7209](http://purl.obolibrary.org/obo/NCIT_C7209) (Childhood B Lymphoblastic Lymphoma), [NCIT:C115357](http://purl.obolibrary.org/obo/NCIT_C115357) (Recurrent Childhood Anaplastic Large Cell Lymphoma), [NCIT:C94794](http://purl.obolibrary.org/obo/NCIT_C94794) (Stage IV Childhood Non-Hodgkin Lymphoma), [NCIT:C94793](http://purl.obolibrary.org/obo/NCIT_C94793) (Stage III Childhood Non-Hodgkin Lymphoma), [NCIT:C94792](http://purl.obolibrary.org/obo/NCIT_C94792) (Stage II Childhood Non-Hodgkin Lymphoma), [NCIT:C115032](http://purl.obolibrary.org/obo/NCIT_C115032) (Stage IV Childhood Anaplastic Large Cell Lymphoma), [NCIT:C94791](http://purl.obolibrary.org/obo/NCIT_C94791) (Stage I Childhood Non-Hodgkin Lymphoma), [NCIT:C9189](http://purl.obolibrary.org/obo/NCIT_C9189) (Recurrent Childhood Burkitt Lymphoma), [NCIT:C115031](http://purl.obolibrary.org/obo/NCIT_C115031) (Stage III Childhood Anaplastic Large Cell Lymphoma), [NCIT:C9124](http://purl.obolibrary.org/obo/NCIT_C9124) (Childhood Lymphoblastic Lymphoma), [NCIT:C115030](http://purl.obolibrary.org/obo/NCIT_C115030) (Stage II Childhood Anaplastic Large Cell Lymphoma), [NCIT:C9187](http://purl.obolibrary.org/obo/NCIT_C9187) (Stage III Childhood Burkitt Lymphoma), [NCIT:C9188](http://purl.obolibrary.org/obo/NCIT_C9188) (Stage IV Childhood Burkitt Lymphoma), [NCIT:C9471](http://purl.obolibrary.org/obo/NCIT_C9471) (Childhood Systemic Anaplastic Large Cell Lymphoma), [NCIT:C9095](http://purl.obolibrary.org/obo/NCIT_C9095) (Childhood Burkitt Lymphoma), [NCIT:C123394](http://purl.obolibrary.org/obo/NCIT_C123394) (Childhood Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue), [NCIT:C68692](http://purl.obolibrary.org/obo/NCIT_C68692) (Childhood Nasal Type Extranodal NK/T-Cell Lymphoma), [NCIT:C7616](http://purl.obolibrary.org/obo/NCIT_C7616) (Childhood Diffuse Large B-Cell Lymphoma), [NCIT:C5636](http://purl.obolibrary.org/obo/NCIT_C5636) (Childhood Anaplastic Large Cell Lymphoma), [NCIT:C5637](http://purl.obolibrary.org/obo/NCIT_C5637) (Childhood Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma), [NCIT:C115029](http://purl.obolibrary.org/obo/NCIT_C115029) (Stage I Childhood Anaplastic Large Cell Lymphoma), [NCIT:C115369](http://purl.obolibrary.org/obo/NCIT_C115369) (Recurrent Childhood Non-Hodgkin Lymphoma), [NCIT:C115204](http://purl.obolibrary.org/obo/NCIT_C115204) (Childhood Grade III Lymphomatoid Granulomatosis), [NCIT:C80299](http://purl.obolibrary.org/obo/NCIT_C80299) (Pediatric Nodal Marginal Zone Lymphoma), [NCIT:C115367](http://purl.obolibrary.org/obo/NCIT_C115367) (Recurrent Childhood Grade III Lymphomatoid Granulomatosis), [NCIT:C7211](http://purl.obolibrary.org/obo/NCIT_C7211) (Childhood Primary Cutaneous Anaplastic Large Cell Lymphoma), [NCIT:C9059](http://purl.obolibrary.org/obo/NCIT_C9059) (Stage IV Childhood Lymphoblastic Lymphoma), [NCIT:C9057](http://purl.obolibrary.org/obo/NCIT_C9057) (Stage II Childhood Lymphoblastic Lymphoma), [NCIT:C9079](http://purl.obolibrary.org/obo/NCIT_C9079) (Childhood Immunoblastic Lymphoma), [NCIT:C9058](http://purl.obolibrary.org/obo/NCIT_C9058) (Stage III Childhood Lymphoblastic Lymphoma), [NCIT:C7210](http://purl.obolibrary.org/obo/NCIT_C7210) (Childhood T Lymphoblastic Lymphoma), [NCIT:C9056](http://purl.obolibrary.org/obo/NCIT_C9056) (Stage I Childhood Lymphoblastic Lymphoma), [NCIT:C9185](http://purl.obolibrary.org/obo/NCIT_C9185) (Stage I Childhood Burkitt Lymphoma), [NCIT:C9186](http://purl.obolibrary.org/obo/NCIT_C9186) (Stage II Childhood Burkitt Lymphoma), [NCIT:C9060](http://purl.obolibrary.org/obo/NCIT_C9060) (Recurrent Childhood Lymphoblastic Lymphoma), 

**Class expressions from DL-Learner:**

- Thing 52.66%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C4020](http://purl.obolibrary.org/obo/NCIT_C4020) (Fibroblastic Osteosarcoma))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40199](http://purl.obolibrary.org/obo/NCIT_C40199) (Cervical Squamous Intraepithelial Neoplasia 1))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40198](http://purl.obolibrary.org/obo/NCIT_C40198) (Cervical Squamous Intraepithelial Neoplasia 2))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40194](http://purl.obolibrary.org/obo/NCIT_C40194) (Cervical Squamotransitional Carcinoma))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40193](http://purl.obolibrary.org/obo/NCIT_C40193) (Cervical Lymphoepithelioma-Like Carcinoma))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40191](http://purl.obolibrary.org/obo/NCIT_C40191) (Cervical Warty Carcinoma))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40190](http://purl.obolibrary.org/obo/NCIT_C40190) (Cervical Verrucous Carcinoma))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C4019](http://purl.obolibrary.org/obo/NCIT_C4019) (Paget Disease and Intraductal Carcinoma of the Breast))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40189](http://purl.obolibrary.org/obo/NCIT_C40189) (Cervical Basaloid Carcinoma))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40187](http://purl.obolibrary.org/obo/NCIT_C40187) (Cervical Keratinizing Squamous Cell Carcinoma))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40182](http://purl.obolibrary.org/obo/NCIT_C40182) (Uterine Corpus Carcinofibroma))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40177](http://purl.obolibrary.org/obo/NCIT_C40177) (Uterine Corpus Smooth Muscle Tumor of Uncertain Malignant Potential))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40175](http://purl.obolibrary.org/obo/NCIT_C40175) (Uterine Corpus Myxoid Leiomyosarcoma))) 39.90%


